» Authors » Allison K Delong

Allison K Delong

Explore the profile of Allison K Delong including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 405
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chay J, Su R, Kamano J, Andama B, Bloomfield G, Delong A, et al.
Lancet Glob Health . 2024 Jul; 12(8):e1331-e1342. PMID: 39030063
Background: The Bridging Income Generation with Group Integrated Care (BIGPIC) trial in rural Kenya showed that integrating usual care with group medical visits or microfinance interventions reduced systolic blood pressure...
2.
Novitsky V, Nyandiko W, Vreeman R, Delong A, Howison M, Manne A, et al.
Viruses . 2023 Jul; 15(7). PMID: 37515104
Drug resistance remains a global challenge in children and adolescents living with HIV (CALWH). Characterizing resistance evolution, specifically using next generation sequencing (NGS) can potentially inform care, but remains understudied,...
3.
Manne A, Delong A, Nyandiko W, Delong A, Vreeman R, Novitsky V, et al.
Microbiol Spectr . 2022 Apr; 10(2):e0267521. PMID: 35389242
HIV-1 drug resistance remains a global challenge, yet access to testing is limited, particularly in resource-limited settings. We examined feasibility and limitations of genotyping using dried filter analytes in treatment-experienced...
4.
Nyandiko W, Holland S, Vreeman R, Delong A, Manne A, Novitsky V, et al.
J Acquir Immune Defic Syndr . 2021 Nov; 89(2):231-239. PMID: 34723922
Background: Long-term impact of drug resistance in perinatally infected children and adolescents living with HIV (CALWH) is poorly understood. We determined drug resistance and examined its long-term impact on failure...
5.
Ruchman S, Delong A, Kamano J, Bloomfield G, Chrysanthopoulou S, Fuster V, et al.
BMJ Open . 2021 Sep; 11(9):e049610. PMID: 34475172
Objectives: Management of cardiovascular disease (CVD) is an urgent challenge in low-income and middle-income countries, and interventions may require appraisal of patients' social networks to guide implementation. The purpose of...
6.
Fichorova R, Delong A, Cu-Uvin S, King C, Jamieson D, Klein R, et al.
Front Cell Infect Microbiol . 2021 Aug; 11:649940. PMID: 34422675
Co-infections with sexually transmittable pathogens are common and more likely in women with disturbed vaginal bacteriome. Among those pathogens, the protozoan parasite (TV) is most common after accounting for the...
7.
Vedanthan R, Kamano J, Chrysanthopoulou S, Mugo R, Andama B, Bloomfield G, et al.
J Am Coll Cardiol . 2021 Apr; 77(16):2007-2018. PMID: 33888251
Background: Incorporating social determinants of health into care delivery for chronic diseases is a priority. Objectives: The goal of this study was to evaluate the impact of group medical visits...
8.
Vedanthan R, Kamano J, Delong A, Naanyu V, Binanay C, Bloomfield G, et al.
J Am Coll Cardiol . 2019 Sep; 74(15):1897-1906. PMID: 31487546
Background: Elevated blood pressure (BP) is the leading global risk factor for mortality. Delay in seeking hypertension care is associated with increased mortality. Objectives: This study investigated whether community health...
9.
Vedanthan R, Kamano J, Lee H, Andama B, Bloomfield G, Delong A, et al.
Am Heart J . 2017 Jun; 188:175-185. PMID: 28577673
Background: Cardiovascular disease (CVD) is the leading cause of mortality worldwide, with >80% of CVD deaths occurring in low and middle income countries (LMICs). Diabetes mellitus and pre-diabetes are risk...
10.
Liu T, Hogan J, Daniels M, Coetzer M, Xu Y, Bove G, et al.
J Acquir Immune Defic Syndr . 2017 May; 75(5):580-587. PMID: 28489730
Objective: Improve pooled viral load (VL) testing to increase HIV treatment monitoring capacity, particularly relevant for resource-limited settings. Design: We developed marker-assisted mini-pooling with algorithm (mMPA), a new VL pooling...